Prognostic risk profiling in COPD using Global Initiative for Chronic Obstructive Lung Disease 2023 ABE and comorbidity assessment: evidence from a register-based COPD cohort
In this large registry-based cohort, group E patients demonstrated the highest mortality and exacerbation risks. Cardiovascular and pulmonary comorbidities increased adverse outcome risks across all GOLD categories. Systematic comorbidity screening should be integrated into routine COPD care. Findings support personalised treatment approaches based on GOLD classification and comorbidity profiles.
Authors
- Chong‐Jen Yu (ORCID: https://orcid.org/0000-0001-5664-9392)
- Po-Chiang Chan
- Hao‐Chien Wang (ORCID: https://orcid.org/0000-0002-7528-7494)
- Inn‐Wen Chong (ORCID: https://orcid.org/0000-0001-8328-8684)
- Kang-Yun Lee (ORCID: https://orcid.org/0000-0002-1203-4094)
- Ching‐Hsiung Lin (ORCID: https://orcid.org/0000-0001-9407-8578)
- Yi‐Rong Li
- Shih–Lung Cheng
- Hen-I Lin
- Huanwei Chen (ORCID: https://orcid.org/0000-0001-9080-6435)
Institutions
- National Yang Ming Chiao Tung University (TW)
- Kaohsiung Medical University (TW)
- National Chung Hsing University (TW)
- Kaohsiung Medical University Chung-Ho Memorial Hospital (TW)
- Far Eastern Memorial Hospital (TW)
- National Taiwan University Hospital (TW)
- Cardinal Tien Hospital (TW)
- Taipei Medical University-Shuang Ho Hospital (TW)
- Changhua Christian Hospital (TW)
- Yuan Ze University (TW)
Publication Details
- Journal
- Journal of Global Health
- Published
- 2025-05-23
- DOI
- https://doi.org/10.7189/jogh.15.04152
- Citations
- 1
- Primary Topic
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Type
- article
- Field-Weighted Citation Impact
- 1.52